Melonfrost logo — The Bioreactor Company

Melonfrost

The Bioreactor Company

Founded 2019 United States Brooklyn, United States 3 employees Seed Total: $13.00M AI, Biotechnology +2

General Information

Company Name Melonfrost
Founded Year 2019
Location United States Brooklyn, United States +1
Employees 3
Industries AI, Biotechnology, Manufacturing +1
Funding Stage Seed
Social

Get notified when Melonfrost moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Melonfrost

Melonfrost, known as The Bioreactor Company, was founded in 2019 with the mission of streamlining biomanufacturing research and development. Operating at the intersection of AI, Biotechnology, Manufacturing, and Robotics, this innovative company is headquartered in the United States.

With a recent $7.00M seed round investment secured on 25 January 2023, Melonfrost has attracted the attention of notable investors such as Refactor Capital and Alexandria Venture Investments. This financial backing underscores confidence in Melonfrost's potential to disrupt the biomanufacturing industry through advanced technological integration.

As an emerging leader in bioreactor technology, Melonfrost offers significant growth potential for investors seeking opportunities in cutting-edge biotech applications. Its focus on R&D optimization positions the company as a compelling candidate for further investment in the biomanufacturing sector.

Taxonomy: biomanufacturing, bioreactors, bioproduct development, R&D streamlining, biotechnological innovations, bioprocess optimization, biotechnical equipment, biomanufacturing efficiency, biotechnology advancements, custom bioreactor design, bioprocess engineering, industrial biotechnology

Services & Products

Online Slot Games
Table and Live Dealer Games
Bonuses and Promotions
Mobile-Optimized Gaming
Secure Payment Processing

Target Customers

Australian Gamblers Global Online Casino Players Cryptocurrency Users Mobile Gaming Enthusiasts Loyalty Program Participants

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 2
Investor Investor
01 Jan 2023
Seed •••••• 6
Investor Investor Investor Investor Investor Investor
01 May 2021

Melonfrost Alternatives & Competitors

View All Alternatives
Melonfrost vs

Development & Licensing of Complex Biologics | Provide Biologics CDMO Services | Produce/supply Biop...

12 employees
Biotechnology, Pharmaceutical
Melonfrost vs
Constructive Bio
Constructive Bio United Kingdom

Life, reimagined.

Unknown
70 employees
Biotechnology
Melonfrost vs
baCta
baCta France

AI-powered bioproduction for industrial ingredients

Seed
16 employees

FAQ About Melonfrost

The Bioreactor Company
Melonfrost was founded in 2019.
Melonfrost is headquartered in Brooklyn, United States.
Melonfrost operates in the following industries: AI, Biotechnology, Manufacturing, Robotics.
Melonfrost has approximately 3 employees.
Melonfrost has completed 2 funding rounds, raising a total of $13.00M. The latest funding stage is Seed.
Melonfrost offers: Online Slot Games, Table and Live Dealer Games, Bonuses and Promotions, Mobile-Optimized Gaming, Secure Payment Processing.
Top alternatives and competitors to Melonfrost include Paras Biopharmaceuticals Finland, Constructive Bio, baCta, Membio Inc., Bioreactors.net. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Melonfrost and Paras Biopharmaceuticals Finland are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Melonfrost and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy